GlassScriptPhysician profile
David Smith Abernathy
NPI 1265497366
$847.01
in general payments reported to CMS, 2019-2025
18 companies · $79.24 in 2025
The $79.24 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $187 · 2021: $182 · 2022: $13.40 · 2025: $79.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $133.83 | 2019-2021 | |
| Amgen INC. | $80.51 | 2019-2020 | |
| Alkermes, INC. | $79.24 | 2025 | Aristada, Lybalvi |
| Astrazeneca Pharmaceuticals LP | $76.54 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $63.93 | 2019-2020 | |
| Novo Nordisk INC | $63.56 | 2019 | |
| Abbvie INC. | $62.25 | 2019-2021 | |
| Shockwave Medical, INC | $59.60 | 2021 | |
| Sanofi-Aventis U.S. LLC | $56.67 | 2019-2020 | |
| Glaxosmithkline, LLC. | $42.64 | 2019-2020 | |
| Lilly USA, LLC | $29.20 | 2020-2022 | |
| Amarin Pharma, INC. | $24.89 | 2019 | |
| Dexcom, INC. | $16.02 | 2021 | |
| Merck Sharp & Dohme LLC | $12.58 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.48 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $11.28 | 2019 | |
| Mylan Specialty L.P. | $10.93 | 2019 | |
| Astellas Pharma US INC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Abernathy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.